@article{ead0eb0b5bb5400ca3f35b0f707f86df,
title = "Reply: BAG3 protein in advanced-stage heart failure",
author = "Storrow, {Alan B.} and Jenkins, {Cathy A.} and Self, {Wesley H.} and Alexander, {Pauline T.} and Barrett, {Tyler W.} and Han, {Jin H.} and McNaughton, {Candace D.} and Heavrin, {Benjamin S.} and Mihai Gheorghiade and Collins, {Sean P.}",
note = "Funding Information: Please note: Dr. Storrow has received grant support from Abbott Diagnostics , NIH / NHLBI (K23HL085387 and K12HL1090), National Center for Advancing Translational Sciences ( UL1TR000445 ), Centers for Disease Control, and Roche Diagnostics . He consults for Roche Diagnostics, Abbott Point-of-Care, Astellas, and Novartis Pharmaceuticals Corp, USA. Dr. Barrett is supported by grant K23HL102069 and serves as a consultant for Red Bull GmbH. Dr. Collins receives research funding from NIH / NHLBI , Medtronic , Cardiorentis , Abbott Point-of-Care , Novartis , The Medicines Company , and Radiometer and consults with Trevena, Novartis, Otsuka, Radiometer, The Medicines Company, Medtronic, and Astellas. Dr. Self has received research funding from the Centers for Disease Control and Prevention , the NIH, Affinium Pharmaceuticals , bioMerieux , Astute Medical , and CareFusion Inc . Dr. Han is supported by funding from the Emergency Medicine Foundation Career Development Award and NIH K23AG032355 , and the National Center for Advancing Translational Sciences UL1 TR000445 . Dr. Gheorghiade has received consulting fees from Bayer, Novartis, Sigma Tau, Johnson & Johnson, Takeda, Otsuka, and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",
year = "2014",
doi = "10.1016/j.jchf.2014.05.013",
language = "English (US)",
volume = "2",
pages = "675",
journal = "JACC: Heart Failure",
issn = "2213-1779",
publisher = "Elsevier BV",
number = "6",
}